Edwards Lifesciences is trading at 116.40 as of the 27th of December 2024, a 1.16% increase since the beginning of the trading day. The stock's open price was 115.06. Edwards Lifesciences has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 3rd of December 2023 and ending today, the 27th of December 2024. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Edwards Lifesciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Edwards Lifesciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Edwards Lifesciences (E1WL34) is traded on Sao Paulo Exchange in Brazil and employs 10 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 250.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Edwards Lifesciences's market, we take the total number of its shares issued and multiply it by Edwards Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Edwards Lifesciences operates under Healthcare sector and is part of Medical Devices industry. The entity has 618.26 M outstanding shares.
Edwards Lifesciences generates positive cash flow from operations, but has no cash available
Check Edwards Lifesciences Probability Of Bankruptcy
Edwards Lifesciences Risk Profiles
Although Edwards Lifesciences' alpha and beta are two of the key measurements used to evaluate Edwards Lifesciences' performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Edwards Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Pattern Recognition Now
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Edwards Lifesciences financial ratios help investors to determine whether Edwards Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Edwards with respect to the benefits of owning Edwards Lifesciences security.